|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
2
Mastering Phase-Appropriate Characterization for Biologics Approval
3
Transforming Clinical Bioanalysis for Manufacturing Scalability
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
